As anticipated, mutations of NES region in BATF2, converting leucine to alanine, significantly repressed its binding to CRM1 and suppressed the nuclear export of BATF2 and subsequent CRC proliferation in vitro and in vivo. This evidence concerns the gene XPO1 and colorectal carcinoma.